Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
China builds frameworks for brain-computer interface implantables, generative AI gets FDA and MHRA attention, and three more key medtech policy focus areas in July and August.
Rajiv Sethi, who led the Seattle Spine Score initiative to make spine surgery outcomes more consistent and effective, speaks to MedTech Strategist about his move from Virginia Mason in Seattle to UCSF. His expansive new remit includes research and implementation of value-based care initiatives in MSK disorders. One example: a quantitative scoring system he and colleagues are proposing for evaluating new technologies aims to reduce variability and subjectivity in decision making.
Medtech investing has maintained its momentum from 2025 through 2026, according to PwC’s latest medtech deals outlook. Excerpted from our recent feature, “As Dollars Chase AI Dream, Investors Stay Grounded.”